Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Renal Failure|July 27, 2007
Carbon monoxide (CO) protects renal tubular epithelial cells against cold-rewarm apoptosisDavid E Stec, Christopher Bishop, John M Rimoldi, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|July 27, 2017
Working Memory and Speech Recognition in Noise Under Ecologically Relevant Listening Conditions: Effects of Visual Cues and Noise Type Among Adults With Hearing LossChristi W Miller, Erin K Stewart, Yu-Hsiang Wu, et al.
Neuropharmacology|March 31, 2015
Modulation of L-DOPA's antiparkinsonian and dyskinetic effects by α2-noradrenergic receptors within the locus coeruleusCorinne Y Ostock, Joy Hallmark, Noel Palumbo, et al.
Frontiers in Neural Circuits|April 16, 2025
Corrigendum: The effects of chemogenetic targeting of serotonin-projecting pathways on L-DOPA-induced dyskinesia and psychosis in a bilateral rat model of Parkinson's diseaseNatalie Lipari, Ashley Galfano, Shruti Venkatesh, et al.
Neuropharmacology|June 25, 2018
Behavioral and cellular dopamine D<sub>1</sub> and D<sub>3</sub> receptor-mediated synergy: Implications for L-DOPA-induced dyskinesiaKathryn Lanza, Samantha M Meadows, Nicole E Chambers, et al.
Molecular Ecology|March 12, 2021
Genetic basis of susceptibility to low-dose paraquat and variation between the sexes in Drosophila melanogasterPamela C Lovejoy, Kate E Foley, Melissa M Conti, et al.
The European Journal of Neuroscience|July 5, 2006
MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulationChristopher Bishop, Jennifer L Taylor, Donald M Kuhn, et al.
Neuroreport|July 28, 2009
Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesiaKaren L Eskow Jaunarajs, Kristin B Dupre, Aimee Steiniger, et al.
Synapse (New York, N.Y.)|March 25, 2009
The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian ratsKaren L Eskow, Kristin B Dupre, Christopher J Barnum, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2017
Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease modelTanya Chotibut, Samantha Meadows, Ella A Kasanga, et al.
Pageof 10